Overview
Rare parenchymal liver disease is a broad classification category used by Orphanet (ORPHA:101939) to group a heterogeneous collection of rare diseases that primarily affect the functional tissue (parenchyma) of the liver. The liver parenchyma is composed mainly of hepatocytes, which are responsible for the organ's critical metabolic, synthetic, and detoxification functions. Diseases within this grouping can affect the liver through various mechanisms including abnormal storage of substances, metabolic dysfunction, inflammatory processes, vascular abnormalities within the liver tissue, and fibrotic or cirrhotic changes. Because this is a classification group rather than a single discrete disease entity, the clinical features, age of onset, inheritance patterns, and treatments vary widely depending on the specific underlying condition. Disorders that fall under this umbrella may include rare forms of hepatitis, rare metabolic liver diseases, congenital hepatic fibrosis, and other conditions that damage or alter liver parenchymal architecture. Symptoms across these conditions may include jaundice, hepatomegaly, elevated liver enzymes, portal hypertension, liver failure, and fatigue. Treatment approaches range from supportive care and dietary management to pharmacological therapies and liver transplantation, depending on the specific diagnosis within this category.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Rare parenchymal liver disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Rare parenchymal liver disease at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Rare parenchymal liver disease.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Rare parenchymal liver disease.
Community
No community posts yet. Be the first to share your experience with Rare parenchymal liver disease.
Start the conversation →Latest news about Rare parenchymal liver disease
No recent news articles for Rare parenchymal liver disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Rare parenchymal liver disease
What is Rare parenchymal liver disease?
Rare parenchymal liver disease is a broad classification category used by Orphanet (ORPHA:101939) to group a heterogeneous collection of rare diseases that primarily affect the functional tissue (parenchyma) of the liver. The liver parenchyma is composed mainly of hepatocytes, which are responsible for the organ's critical metabolic, synthetic, and detoxification functions. Diseases within this grouping can affect the liver through various mechanisms including abnormal storage of substances, metabolic dysfunction, inflammatory processes, vascular abnormalities within the liver tissue, and fibr